BioServices: Marketplace for service providers in the pharmaceuticals and biotech industry
“Speed Dating” to increase networking effectiveness
The BioServices Marketplace is one of four new marketplace-style displays at Biotechnica 2013. It is a central gathering point where representatives of pharmaceuticals and biotech companies can meet up with a broad international cross-section of drug development service providers, make new contacts and lay the groundwork for promising new business relationships. The BioServices Marketplace also comprises a special display for providers and developers of services and solutions for the biopharmaceuticals industry, plus a forum for company lectures on current biopharmaceutical-sector issues and trends, such as biomarkers in clinical development, new types of antibodies, modern genome analysis and cooperative manufacturing models.
There will also be a daily “Speed Dating” session for streamlined networking between representatives of biotech and pharmaceuticals companies and providers of services and solutions from the commercial and academic sectors. This is an important offering, because networking and partnership are crucial to new drug research and development in the biotech and pharmaceuticals sector. In many cases, drug companies don’t possess all the technical expertise needed to develop new drugs, and so it makes sense for them to outsource certain development, testing, approval and production tasks to external providers. This partnership model is also an effective way of managing risk and minimizing costs.
The marketplace character of the BioServices section of BIOTECHNICA 2013 makes it easy for potential customers to find the service providers they are looking for. Companies can also participate as exhibitors and further boost their profile by giving presentations at the lecture forum.
Topics
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous

Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous